Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT03291457
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of moderate to severe RA, defined as DAS28 greater than or equal to 3.7
* Naive to tocilizumab, or received tocilizumab within 8 weeks prior to enrollment
* Physician has made decision to commence IV or SC tocilizumab in accordance with label and reimbursement criteria
* Treated with glucocorticoids for RA when starting tocilizumab treatment
Exclusion Criteria:
* Treatment with any investigational agent within 4 weeks or 5 half-lives before tocilizumab
* Continuous or regular treatment with oral corticosteroids for any indication other than RA
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03291457
Study Brief:
Protocol Section:
NCT03291457